Avieum Life Sciences is Drug Discovery in India that focus on Provider business. They cover business area such as Provider, drug discovery service, global pharmaceutical r&d organization, their drug discovery research, hit identification, optimization, custom synthesis, impurity synthesis, reference standard, route scouting, process development, patient, fast cure, various chronic disease.
-
Provider
-
International Biotech Park, Genesis Square
Ground floor, MIDC, Hinjewadi Phase II, MAAN
Pune, Maharastra 411057
India
Private
Providerdrug discovery serviceglobal pharmaceutical r&d organizationtheir drug discovery researchhit identificationoptimizationcustom synthesisimpurity synthesisreference standardroute scoutingprocess developmentpatientfast curevarious chronic disease
* We use standard office opening hours in near Avieum Life Sciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Avieum Life Sciences is Drug Discovery business from India that founded in - ( years old in ), Avieum Life Sciences business is focusing on Provider.
Avieum Life Sciences headquarter office and corporate office address is located in International Biotech Park, Genesis Square Ground floor, MIDC, Hinjewadi Phase II, MAAN Pune, Maharastra 411057 India.
Avieum Life Sciences was founded in India.
In , Avieum Life Sciences is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Avieum Life Sciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.